Ks located at -Fe2O3 (JCPDS No.: 39-1346). No more peaks have been observed in the

Ks located at -Fe2O3 (JCPDS No.: 39-1346). No more peaks have been observed in the XRD pattern, confirming the purity of your solutions. To be able to explore the impact of temwhereas the peaks at (220), (311), (400), (422), and (511) (Marked as) show diffraction plate, we prepared -Fe2O3/WO3-Fe2 O3 within the absence39-1346). No further peaks 1c) observed in peaks located at .5H2O (JCPDS No.: of PAF-50. The results (Figure had been showed that inthe XRD pattern, confirming the purity of the2O3. We inferred that to explore the effect the products Fe3O4 did not turn out to become -Fe goods. In order PAFof template, oxidize Fe3O to -Fe /WO3 in accumulating metal ions to 50 played a part helping to we ready 4-Fe2 O32O3 and0.5H2 O in the absence of PAF-50. The outcomes (Figure 1c) type a complex [26,45,48]. showed that in the items Fe3 O4 did not turn out to become -Fe2 O3 . We inferred that PAF-50 played a part helping to oxidize Fe3 O4 to -Fe2 O3 and in accumulating metal ions to form a complex [26,45,48].aIntensity (a.u.)(311)(400)(220)(222)(331)Fe3O4 JCPDS:65-20 40Two Theta (degree)b(311)(222) (220)(111)(422)##(422) (400) (511) (400) (311) (331)(440) (531)#IntensitySample####(422)# WO30.5H2O JCPDS 84–Fe2O3 JCPDS 39-Figure 1. Cont.Two Theta (degree)(511) (533) (622)##(511) -Fe2O# WO30.5H2O(440)#Molecules 2021, 26, 6857 Molecules 2021, 26, 6857 lecules 2021, 26,five five of 15 of5 ofCCIntensity (a.u.) Intensity (a.u.)#Fe3 Fe3O4 O# WO3 O # WO30.5H20.5H2O########### # ### ##Fe3O4 3O4 JCPDS 65-3107 Fe JCPDS 65-WO3WO 0.5H O JCPDS 84-1851 0.5H2O JCPDS 84-320Two Theta (degree) Two Theta (degree)Figure 1. (a) Indexed Ceftizoxime sodium manufacturer powder XRD pattern of your Fepattern in the Fe3ICDD files of Fe3OICDD files of Fe3 O4 ; (b) indexed Figure 1. powder XRD pattern in the 4 goods and and ICDD files of Fe3O4; (b) indexed Figure 1. (a) Indexed (a) Indexed powder XRD 3OFe3O4 productsO4 items and four; (b) indexed powder XRD pattern of -Fe2O3/WO3.5H2O samples and ICDD files of -Fe2O3 and WO3.5H2O; powder XRD pattern of -Fe2 O3 O samples two O ICDD files ICDD O3 and WO3.5H2O; powder XRD pattern of -Fe2O3/WO3.5H2/WO3 .5Handsamples andof -Fe2files of -Fe2 O3 and WO3 .5H2 O; (c) indexed powder XRD pattern of the samples prepared in the absence of PAF-50. (c) indexed(c) indexed powder XRDthe samplesthe samples prepared in thePAF-50. of PAF-50. powder XRD pattern of pattern of prepared inside the absence of absenceXPS spectra have been performed to determine the valence state in the components. Figure XPS spectra have been performed to figure out the valence state of the elements. XPS spectra have been performed to decide the valence state of your components. Figure Figure 2b 2b shows the spectrum of Fe 2p; the places at 711.1 and 724.8 eV correspond to Fe 2p3/2 shows the spectrum of Fe 2p; the areas at 711.1 eV 724.8 eV correspond 2b shows the spectrum of Fe 2p; the Hydroxystilbamidine bis MedChemExpress locations at 711.1 and 724.8and correspond to Fe 2p3/2 to Fe 2p3/2 and Fe 2p1/2 [54,55]. The satellite peak of Fe 2p3/2 for Fe2O3 is located roughly 8 eV and Fe 2pand Fe 2p1/2 [54,55]. The satellite peak forFe 2p 3 is for Fe2 Oapproximately 8 eV 1/2 [54,55]. The satellite peak of Fe 2p3/2 of Fe2O positioned three is situated around eight eV greater than the key Fe 2p3/2 peak. Additionally, there seems 3/2be another satellite peak to greater than the main Fe In addition, there seems to appears to be a different satellite peak greater than the key Fe 2p3/2 peak.2p3/2 peak. Moreover, there be one more satellite peak at 733.five eV, which might be a.